Transcatheter Interventions Online 2022 - On Demand

Published: 09 March 2022

  • Views:

    Views Icon 45752
  • Likes:

    Heart Icon 7
  • episode_image
    1h 2m 19s
    Part 1 | Session 2 Session 1.2: Live Cases and Discussion Lars Søndergaard, Ole De Backer, Holger Thiele, Nicolas M Van Mieghem, Azeem Latib, Kendra J Grubb, David Hildick-Smith, Mohamed Abdel-Wahab
  • episode_image
    57m 43s
    Part 2 | Session 2 Session 2.2: Live Cases and Discussion George D Dangas, Holger Thiele, Ajay J Kirtane, Joost Daemen, Margaret McEntegart, Azeem Latib, Didier Tchétché, Annapoorna Kini
  • episode_image
    56m 37s
    Part 2 | Session 5 Session 2.4: Live Cases and Discussion Roxana Mehran, David Hildick-Smith, Holger Thiele, Nicolas M Van Mieghem, Ajay J Kirtane, Margaret McEntegart, Roberto Diletti
  • episode_image
    59m 54s
    Part 3 | Session 2 Session 3.3: Live Cases and Discussion Roxana Mehran, Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, Lars Søndergaard, Philipp Lurz, Joost Daemen, Christian Besler
  • episode_image
    1h 3m 33s
    Part 3 | Session 4 Session 3.4: Debates Nicolas M Van Mieghem, Ajay J Kirtane, Roxana Mehran, Philipp Lurz
Average (ratings)
No ratings
Your rating

Overview

Following on from the success of 2021's inaugural edition, Transcatheter Interventions Online 2022  brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.
 

Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2022 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.

 

Note, the live version of this session was CME accredited; this on-demand version is not.

 

 

 

 

Transcatheter Interventions Online 2022 was supported by the following partners:

Key Learning Objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation

Target Audience

  • Interventional Cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional Cardiology Nurses

More from this programme

Faculty Biographies

Didier Tchétché

Didier Tchétché

Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.

In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.

View full profile
Lars Søndergaard

Lars Søndergaard

Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

View full profile
Ran Kornowski

Ran Kornowski

Prof Ran Kornowski, MD, FACC, FESC is the Director of the Cardiology Division at Rabin Medical Center (RMC) in Petach Tikva, Israel. He is a full Professor of Cardiovascular Medicine at the Faculty of Medicine, Tel Aviv University and until very recently he served as the President of the Israeli Heart Society.

Previously he also served as the Chairman of the Israeli Association of Interventional Cardiology 2009-13. Prof Kornowski established a cardiovascular research institute within his hospital conducting multiple clinical trials and translational research projects designated towards best innovative patient's care. He is a member of the leading cardiology societies worldwide.

View full profile
Douglas G Fraser

Douglas G Fraser

Dr Douglas Fraser trained preclinical in Oxford and clinical in Cambridge, qualifying in 1991. House jobs in Addenbrooke’s, SHO and registrar training in the West Midlands including QE Birmingham, Walsgrave Coventry, North Staffordshire. One year fellowship in Amsterdam.

Recognised as expert in radial angioplasty. Active publication record in interventional cardiology

View full profile